Latent EBV Just May Promote Cancer Growth

0 Flares Twitter 0 Facebook 0 LinkedIn 0 Google+ 0 0 Flares ×

cancer growth

“Most EBV associated cancers contain viral DNA that exists predominantly as a latent infection. – ACS Chemical Biology (1)

Most members in the medical community still believe that latent (also called dormant) viruses are inactive and harmless. However, a recent study showed that the latent EBV promotes tumor progression. The problem is that there are no approved drugs that target the latent EBV. However, there are drugs that kill the active virus.

The authors of this study proposed a clever solution. The solution is called “oncolytic therapy.” It first uses drugs that reactivate the latent virus. Then, it uses another drug that kills the active virus (1).

However, there may be an even better solution. Why not use a clinically backed natural product to help the immune system target the latent virus directly?

As the study by researchers from The Wistar Institute noted, “latent infection can drive the formation of Burkitt’s lymphoma (BL), Hodgkin lymphomas, nasopharyngeal carcinoma (NPC), and gastric carcinoma (GC). Latent infection with EBV is a major cause of post-transplant lymphoproliferative disease in immunosuppressed patients and greatly enhances risk of developing non-Hodgkin and primary CNS lymphomas in the HIV-positive population (1).”

cancer genes

The study also said that “Most EBV associated cancers contain viral DNA that exist predominantly as a latent infection in which only a limited set of viral genes are expressed. These latency associated genes are implicated in host-cell proliferation and survival, and latent EBV can directly promote tumor progression (1).”

It should be noted that The Wistar Institute study is consistent with the Microcompetition with Foreign DNA Theory proposed by Dr. Hanan Polansky as shown on the website (2).

Dr. Hanan Polansky discovered that foreign DNA fragments, called N-boxes, cause most major diseases.

When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent (dormant), or the viral DNA is broken into pieces and cannot express proteins.

As predicted by Dr. Hanan Polansky, many studies (such as the Wistar study) found latent viruses in tumors.

The bottom line?


“We kept hearing crazy stuff from medical doctors. Some have the idea that latent viruses don’t replicate and so they don’t harm people. Clearly though, these individuals are not well informed about the role of latent viruses in disease.” – Greg Bennett, CBCD


(1) Tikhmyanova N1, Schultz DC, Lee T, Salvino JM, Lieberman PM. “Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.” ACS Chem Biol. 2014 Mar 21;9(3):785-95



Leave a Reply